DUODENAL PH IN CYSTIC-FIBROSIS AND ITS RELATIONSHIP TO FAT MALABSORPTION

被引:73
|
作者
ROBINSON, PJ [1 ]
SMITH, AL [1 ]
SLY, PD [1 ]
机构
[1] ROYAL CHILDRENS HOSP, DEPT GASTROENTEROL, PARKVILLE, VIC 3052, AUSTRALIA
关键词
cystic fibrosis; fat malabsorption; pH;
D O I
10.1007/BF01536423
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To investigate the relationship between duodenal pH levels and supplemental pancreatic enzyme function in cystic fibrosis, 18 children with this condition had pH recordings performed from the second and fourth part of the duodenum. Compared to age-matched controls, patients with cystic fibrosis had significantly longer periods below a pH of 4.0 in the postprandial period and significantly less time above pH 5.8. These values correspond to the pH levels at which lipase is irreversibly destroyed (pH 4.0) and enteric coating of enzyme supplements dissolves (pH 5.8). A significant relationship was found between the pH recordings from the fourth part of the duodenum and the degree of residual fat malabsorption while taking enteric-coated enzyme supplements. Four patients with an excessively acidic duodenum and residual fat malabsorption despite high-dose enzyme supplementation were treated with misoprostol (Searle), a known acid-reducing agent. There were significant improvements in both duodenal pH values and fat absorption. We conclude that there is a wide range of duodenal pH values found in patients with cystic fibrosis and that the efficiency with which enzyme supplements work is closely related to these pH levels. Administration of misoprostol to those patients with excessively acidic duodenal pH levels as well as residual malabsorption appears to be of benefit in improving both the excessively acidic pH levels and the fat malabsorption. © 1990 Plenum Publishing Corporation.
引用
收藏
页码:1299 / 1304
页数:6
相关论文
共 50 条
  • [41] SPECIFIC VITAMIN-B12 MALABSORPTION IN A PATIENT WITH CYSTIC-FIBROSIS
    YADDANAPUDI, R
    SIRMOKADAM, BR
    CARMEL, R
    CHANG, N
    ZUELZER, WW
    PEDIATRIC RESEARCH, 1973, 7 (04) : 341 - 341
  • [42] CYSTIC-FIBROSIS - ITS SURGICAL PRESENTATION
    SWAN, HAP
    CHAPPELL, JS
    SOUTH AFRICAN JOURNAL OF SURGERY, 1979, 17 (02) : 51 - 57
  • [43] CYSTIC-FIBROSIS - ITS BIOCHEMICAL DETECTION
    HEELEY, AF
    WATSON, D
    CLINICAL CHEMISTRY, 1983, 29 (12) : 2011 - 2018
  • [44] CYSTIC-FIBROSIS .1. PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS AND ITS MANAGEMENT
    HOIBY, N
    KOCH, C
    THORAX, 1990, 45 (11) : 881 - 884
  • [45] EFFICACY OF A NONRESTRICTED FAT DIET IN PATIENTS WITH CYSTIC-FIBROSIS
    LUDER, E
    KATTAN, M
    THORNTON, JC
    KOEHLER, KM
    BONFORTE, RJ
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (04): : 458 - 464
  • [46] OMEPRAZOLE IMPROVES FAT-ABSORPTION IN CYSTIC-FIBROSIS
    BARRACLOUGH, M
    TAYLOR, CJ
    GUT, 1992, 33 (02) : S22 - S22
  • [47] THE PREVALENCE OF CUTANEOUS HYPERSENSITIVITY AND ITS RELATIONSHIP TO PSEUDOMONAS COLONIZATION AND OUTCOME IN CYSTIC-FIBROSIS
    HAMILTON, AH
    CARSWELL, F
    CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 (04): : 415 - 419
  • [48] CYSTIC-FIBROSIS
    HARWOOD, I
    ROSAS, F
    EDWARDS, DK
    KELSO, J
    NYHAN, WL
    WESTERN JOURNAL OF MEDICINE, 1988, 148 (01): : 62 - 69
  • [49] CYSTIC-FIBROSIS
    WELSH, MJ
    SMITH, AE
    SCIENTIFIC AMERICAN, 1995, 273 (06) : 52 - 59
  • [50] CYSTIC-FIBROSIS
    AITKEN, ML
    FIEL, SB
    DM DISEASE-A-MONTH, 1993, 39 (01): : 3 - 52